Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Moderna, inc. crawled time : 14:00 save search
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
Published: 2023-12-12 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -0.93%
H: 0.18%
C: -3.94%
commercial
Revolution Medicines Completes Acquisition of EQRx
Published: 2023-11-09 (Crawled : 14:00) - globenewswire.com
RVMD | $36.45 4.38% 4.2% 920K
|
Health Technology
|
| O: 1.04%
H: 1.89%
C: -6.45%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.56%
H: 0.08%
C: -3.11%
acquisition
Moderna Tops BioSpace’s Best Places to Work Ranking for Third Consecutive Year
Published: 2023-11-07 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.21%
H: 2.08%
C: 1.99%
work year
Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC
Published: 2023-10-31 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -1.57%
H: 4.44%
C: 4.18%
pre-clinical mrna collaboration platform
UMass Chan Medical School announces enrollment in study to examine impact of cytomegalovirus (CMV) transmission in early education settings
Published: 2023-08-14 (Crawled : 14:00) - prnewswire.com
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: -0.86%
cytomegalovirus education impact medical study
Senda Biosciences Appoints Igor Matushansky as Chief Medical Officer
Published: 2023-07-24 (Crawled : 14:00) - biospace.com/
OMGA | $2.39 -0.42% -0.42% 190K
|
|
| O: 0.0%
H: 0.19%
C: -6.06%
SANA | $7.96 4.6% 4.4% 2.1M
|
|
| O: -0.16%
H: 3.52%
C: -2.13%
MCRB | $0.6201 10.75% 9.71% 4.2M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: -4.36%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.0%
H: 0.02%
C: -2.71%
FHTX | $5.085 -4.06% -4.23% 78K
|
Health Technology
|
| O: 0.49%
H: 3.56%
C: 1.35%
DNLI | $15.99 -0.06% -0.06% 3.1M
|
Health Technology
|
| O: -0.07%
H: 0.34%
C: -2.47%
medical
Cellarity Strengthens Executive Leadership Team
Published: 2023-04-11 (Crawled : 14:00) - biospace.com/
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: 0.21%
H: 16.84%
C: 11.73%
OMGA | $2.39 -0.42% -0.42% 190K
|
|
| O: -0.38%
H: 2.44%
C: 1.67%
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 0.75%
H: 1.87%
C: 0.75%
SANA | $7.96 4.6% 4.4% 2.1M
|
|
| O: 0.0%
H: 11.28%
C: 11.28%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.06%
H: 0.52%
C: -0.09%
MCRB | $0.6201 10.75% 9.71% 4.2M
|
Health Technology
|
| O: 1.59%
H: 4.17%
C: 1.56%
SELB 4 | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: 0.0%
H: 2.33%
C: 1.55%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -4.82%
H: 2.85%
C: 1.85%
FHTX | $5.085 -4.06% -4.23% 78K
|
Health Technology
|
| O: 0.43%
H: 7.91%
C: 6.21%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 38.25%
H: 0.0%
C: -38.93%
DNLI | $15.99 -0.06% -0.06% 3.1M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -0.75%
Moderna to Present at Cowen's 43rd Annual Health Care Conference
Published: 2023-02-28 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.0%
H: 1.95%
C: 0.39%
care conference health
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: 1.22%
H: 0.0%
C: -1.61%
MRK | $126.94 0.92% 0.0% 7.8M
|
Health Technology
|
| O: -2.77%
H: 1.72%
C: -0.54%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.37%
H: 1.07%
C: 0.66%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -1.44%
H: 0.0%
C: 0.0%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -0.52%
H: 1.92%
C: 1.7%
financial results
Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.8%
H: 3.61%
C: 1.18%
mrna update
mRNA Platform Global Market Report 2022: A Game Changer for Flu Viruses Eluding Conventional Vaccine Efforts
Published: 2022-07-15 (Crawled : 14:00) - prnewswire.com
SGMO | News | $0.5151 0.7% 0.7% 1.3M
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -1.94%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.68%
H: 3.73%
C: 3.67%
global report vaccine mrna platform market
Moderna Receives FDA Authorization for Emergency Use of Its COVID-19 Vaccine for Children 6 Months of Age and Older
Published: 2022-06-17 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -0.29%
H: 6.66%
C: 6.05%
covid-19 fda children vaccine authorization order
Alnylam Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity
Published: 2022-04-28 (Crawled : 14:00) - biospace.com/
PFE | News A | $26.26 1.0% -0.08% 36M
|
Health Technology
|
| O: 1.41%
H: 0.65%
C: 0.14%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -2.65%
H: 3.28%
C: -0.84%
ALNY | $145.78 0.95% 0.94% 390K
|
Health Technology
|
| O: -2.94%
H: 0.63%
C: -4.79%
results
Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform
Published: 2022-04-19 (Crawled : 14:00) - biospace.com/
OMGA | $2.39 -0.42% -0.42% 190K
|
|
| O: -0.56%
H: 4.31%
C: -4.13%
SANA | $7.96 4.6% 4.4% 2.1M
|
|
| O: -0.13%
H: 2.81%
C: 0.67%
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: 3.05%
H: 2.22%
C: -1.48%
MCRB | $0.6201 10.75% 9.71% 4.2M
|
Health Technology
|
| O: 0.89%
H: 3.51%
C: 1.93%
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 0.58%
H: 1.74%
C: -6.98%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -8.13%
H: 1.25%
C: 0.63%
FHTX | $5.085 -4.06% -4.23% 78K
|
Health Technology
|
| O: 0.38%
H: 2.4%
C: 0.3%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 0.43%
H: 1.3%
C: -0.43%
DNLI | $15.99 -0.06% -0.06% 3.1M
|
Health Technology
|
| O: 1.12%
H: 1.72%
C: -1.87%
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 0.0%
H: 3.63%
C: -1.04%
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 0.0%
H: 3.11%
C: 1.55%
therapeutics platform
Moderna Files for Authorization of its COVID-19 Vaccine with Health Canada to Include Children Ages 6-11 Years
Published: 2021-11-17 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
covid children vaccine
Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: 0.0%
phase 2 positive
Moderna Announces Swissmedic Authorizes Booster Dose of Moderna’s COVID-19 Vaccine
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
covid vaccine covid-19
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older
Published: 2021-10-05 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: 1.58%
H: 2.12%
C: 0.34%
covid europe vaccine authorized order
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
Published: 2021-09-17 (Crawled : 14:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
CVAC | $2.525 3.48% 3.37% 600K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
BNTX | News | $88.01 1.38% 1.36% 390K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
covid cancer vaccine technology covid-19
Moderna and the Institute for Life Changing Medicines Announce a New Collaboration to Develop an mRNA Therapeutic for Ultra-Rare Disease, Crigler-Najjar Syndrome Type 1
Published: 2021-09-07 (Crawled : 14:00) - biospace.com/
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -1.73%
H: 7.09%
C: 6.57%
disease collaboration syndros rare
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.